Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

In a report released on July 30, Nicolas Pauillac from Kepler Capital maintained a Hold rating on GlaxoSmithKline, with a price target of p1,500.00. The company’s shares closed yesterday at p1,418.00.

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.

President Trump sent letters Thursday to 17 of the world’s largest drug companies, telling them to take more steps to slash ...

GlaxoSmithKline ‘s spinoff of its consumer health business will allow the remaining company to grow sales by more than 5% a year for the next half-decade, but at the near-term cost of a hefty ...

Pharmaceutical giant GlaxoSmithKline PLC GSK 0.59% pledged to accelerate growth and gave further details of the long-planned separation of its consumer-healthcare business, as it seeks to ward off ...

GlaxoSmithKline PLC and partner Vir Biotechnology Inc. are straining to meet soaring demand for their Covid-19 antibody treatment after the highly mutated Omicron variant knocked out the two ...

GlaxoSmithKline (GSK-0.81%) has confirmed plans to separate its consumer and pharmaceutical business units. However, an activist investor appears to want the big drugmaker to take more drastic ...